These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15462254)

  • 21. Adverse drug reactions, MedWatch reporting and medical student education.
    Lewis LD; Nierenberg DW
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):93-5. PubMed ID: 12642972
    [No Abstract]   [Full Text] [Related]  

  • 22. MedWatch: the new medical products reporting program.
    Couig MP; Merkatz RB
    Am J Nurs; 1993 Aug; 93(8):65-8. PubMed ID: 8256839
    [No Abstract]   [Full Text] [Related]  

  • 23. Adverse drug reactions: getting information back from MEDWATCH.
    Vogt CL; Byrns PJ
    JAMA; 1994 Aug 24-31; 272(8):590-1. PubMed ID: 8057507
    [No Abstract]   [Full Text] [Related]  

  • 24. WHO's international drug monitoring--the formative years, 1968-1975: preparatory, pilot and early operational phases.
    Venulet J; Helling-Borda M
    Drug Saf; 2010 Jul; 33(7):e1-e23. PubMed ID: 20553053
    [No Abstract]   [Full Text] [Related]  

  • 25. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
    Kessler DA
    J Am Podiatr Med Assoc; 1994 Jan; 84(1):35-8. PubMed ID: 8295131
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting.
    Tsong Y
    J Biopharm Stat; 1995 Mar; 5(1):95-114. PubMed ID: 7613562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems.
    Kessler DA
    Gen Hosp Psychiatry; 1994 Mar; 16(2):96-101; discussion 102. PubMed ID: 8039699
    [No Abstract]   [Full Text] [Related]  

  • 28. Accessing Food and Drug Administration Resources in Clinical Practice: A Primer for the Practicing Gastroenterologist.
    Shah ED; Beaulieu DB; Yacyshyn B;
    Am J Gastroenterol; 2019 Oct; 114(10):1688-1690. PubMed ID: 31464738
    [No Abstract]   [Full Text] [Related]  

  • 29. Reporting adverse vaccine events.
    O'Rourke K
    J Am Vet Med Assoc; 2003 Sep; 223(6):753-4. PubMed ID: 14507079
    [No Abstract]   [Full Text] [Related]  

  • 30. Postmarketing surveillance: beyond MEDWatch.
    Faich GA
    JAMA; 1993 Nov; 270(18):2180. PubMed ID: 8411596
    [No Abstract]   [Full Text] [Related]  

  • 31. The pharmacovigilance system in India.
    Kshirsagar N
    Drug Saf; 2005; 28(7):647-50. PubMed ID: 15963010
    [No Abstract]   [Full Text] [Related]  

  • 32. The vaccine adverse event reporting system.
    Varricchio F
    J Toxicol Clin Toxicol; 1998; 36(7):765-8. PubMed ID: 9865252
    [No Abstract]   [Full Text] [Related]  

  • 33. The MedWatch Program.
    Love L; Couig MP
    J Toxicol Clin Toxicol; 1999; 37(6):803-7. PubMed ID: 10584596
    [No Abstract]   [Full Text] [Related]  

  • 34. Predictability of serious adverse reaction alerts for monoclonal antibodies.
    Stanulovic V; Zelko R; Kerpel-Fronius S
    Int J Clin Pharmacol Ther; 2011 Mar; 49(3):185-90. PubMed ID: 21329620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serious adverse events in Norplant users related to the Food and Drug Administration's MedWatch Spontaneous Reporting System.
    Chez RA
    Obstet Gynecol; 1995 Jul; 86(1):154-5. PubMed ID: 7784014
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluating the completeness and accuracy of MedWatch data.
    Getz KA; Stergiopoulos S; Kaitin KI
    Am J Ther; 2014; 21(6):442-6. PubMed ID: 23011177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of databases in drug postmarketing surveillance.
    Rodriguez EM; Staffa JA; Graham DJ
    Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MedWatch. On lookout for medical product problems.
    Ropp KL
    FDA Consum; 1993 Nov; 27(9):14-7. PubMed ID: 10130376
    [No Abstract]   [Full Text] [Related]  

  • 40. Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System.
    Woo EJ; Moro PL; Cano M; Jankosky C
    Vaccine; 2017 Oct; 35(42):5618-5621. PubMed ID: 28886946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.